Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Uncovering TK2d: How to Navigate Diagnostic Challenges
A Closer Look at the Biology Behind MS Progression
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
The New Era of Targeted Therapy for Myasthenia Gravis
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Discharge Planning After Myasthenic Crisis
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.